Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

IRB

Showing results (631-640 of 778) with videos related to

Pageof 78
Sort By:
IRB|November 1, 1982
An executive committee system for IRBsDavid A Blake
IRB|January 1, 1983
The Food and Drug Administration's role in the protection of human subjectsStuart L Nightingale
IRB|May 1, 1983
Deception in social research III: the nature and limits of debriefingJoan E Sieber
IRB|September 1, 1983
Research records, litigation, and confidentiality: the case of research on toxic substancesTroyen A Brennan
IRB|July 1, 1984
IRBs and epidemiologic research: how inappropriate restrictions hamper studiesCristina I Cann, Kenneth J Rothman
IRB|May 1, 1984
Success in spite of failure: why IRBs falter in reviewing risks and benefitsPeter C Williams
IRB|November 1, 1985
Is this a job for the IRB? The case of the ELISA assayAngela R Holder
IRB|November 1, 1985
The internal IRB structure: models in academic settingsG Harry Stopp
IRB|February 1, 1982
Whistleblowing in biomedical research: report from a workshopBarbara Mishkin
IRB|January 1, 1987
AIDS prevention among IV drug users: potential conflicts between research design and ethicsDon C Des Jarlais, Samuel R Friedman
Pageof 78

Showing results (631-640 of 778) with videos related to

Sort By:
Pageof 78
IRB|November 1, 1982
An executive committee system for IRBsDavid A Blake
IRB|January 1, 1983
The Food and Drug Administration's role in the protection of human subjectsStuart L Nightingale
IRB|May 1, 1983
Deception in social research III: the nature and limits of debriefingJoan E Sieber
IRB|September 1, 1983
Research records, litigation, and confidentiality: the case of research on toxic substancesTroyen A Brennan
IRB|July 1, 1984
IRBs and epidemiologic research: how inappropriate restrictions hamper studiesCristina I Cann, Kenneth J Rothman
IRB|May 1, 1984
Success in spite of failure: why IRBs falter in reviewing risks and benefitsPeter C Williams
IRB|November 1, 1985
Is this a job for the IRB? The case of the ELISA assayAngela R Holder
IRB|November 1, 1985
The internal IRB structure: models in academic settingsG Harry Stopp
IRB|February 1, 1982
Whistleblowing in biomedical research: report from a workshopBarbara Mishkin
IRB|January 1, 1987
AIDS prevention among IV drug users: potential conflicts between research design and ethicsDon C Des Jarlais, Samuel R Friedman
Pageof 78